As the landscape of controlled substances continues to evolve, we may be facing a new chapter in the ongoing opioid crisis—this time centered on nitazenes. In this webinar, we’ll explore how the MX908 serves as a vital tool for identifying and combating this emerging threat. Join us as we examine the parallels between the current nitazene challenge and the early stages of the fentanyl crisis, emphasizing the critical need for proactive detection and analysis.

Our focus is on maximizing the capabilities of the MX908 to address the shifting dynamics of the drug landscape. By promoting a deep understanding of advanced technologies and their effectiveness in analyzing highly toxic synthetic opioids, we aim to equip law enforcement, forensic experts, and medical examiners with the tools they need. This strategy is designed to strengthen investigative efforts and mitigate challenges similar to those encountered during the rise of fentanyl.

We will explore real-world cases to highlight the pressing need for updated testing protocols and effective interpretation of MX908 data. This webinar is designed to empower professionals with the insights and strategies necessary to stay at the forefront of controlled substance detection and analysis.

  • Insights into synthetic opioids like fentanyl analogs and nitazenes, as well as hazardous adulterants such as xylazine.
  • An understanding of the emerging threat posed by nitazenes and their similarities to the fentanyl crisis.
  • Knowledge of how the MX908 aids in detecting and identifying emerging drug threats, including opioids and other novel substances.
  • Enhanced proficiency in operating the MX908, with a focus on its critical applications in the field, forensic laboratories, and medical examinations.

Emily Dunn, a Forensic Chemist II at 908 Devices in Boston, MA, holds an M.F.S. in forensic chemistry from The George Washington University and a B.S. in Chemistry from Northeastern University. Throughout her studies, she focused on novel forensic techniques for the analysis of drugs, explosives, and fire debris and collaborated with the ATF to research hypergolic mixtures used in arson. At 908 Devices, Dunn provides Reachback support to MX908 users worldwide by interpreting high-pressure mass spectral data obtained from narcotic, explosive, and chemical warfare agent analysis. As a certified MX908 trainer, she leads trainings for new users, assists in the advancement of training curriculum, and is developing new techniques for MX908 field sampling. Dunn also follows drug trends closely to develop novel psychoactive substances as new targets for the MX908 and was invited to speak internationally on trace drug analysis in 2024.